Table 1.
Patient characteristics
| Total no. of patients | 108 |
|---|---|
| Sex: male/female | 63/45 |
| Total colonoscopy | 199 |
| Number of colonoscopies | |
| 1 | 58 |
| 2 | 30 |
| ≧3 | 20 |
| Age during colonoscopy: median (range) | 44 (12–72) years |
| Disease duration during colonoscopy: median (range) | 9 (0–38) years |
| Montreal classification (%) | |
| E1/E2/E3 | 38 (19.1)/47 (23.6)/114 (57.3) |
| Clinical score at colonoscopy: median (range) | |
| CAI | 0 (0–4) |
| Mayo endoscopic score: median (range) | 1 (0–3) |
| Blood examination: median (range) | |
| CRP | 0.04 (0.02–1.09) |
| SAA | 5.5 (5.5–90.1) |
| Therapies (%) | |
| Mesalamine | 178 (89.4) |
| Corticosteroids | 18 (9.0) |
| Immunomodulators | 71 (35.7) |
| Biologics | 24 (12.1) |
CAI Clinical activity index, CRP C-reactive protein, SAA Serum amyloid A